Utilizing Genomics to Identify Novel Immunotherapeutic Targets in Multiple Myeloma High-Risk Subgroups https://www.biorxiv.org/content/10.1101/2025.01.29.635544v1
03.02.2025 03:37 β π 3 π 2 π¬ 0 π 1
Myeloma / Plasma Cell Dyscrasia ~ #ASH24Top10 (or so) #mmsm #mmMRD #ASH24 - @mtmdphd *DRAFT* Table Update: Nov 18, 2024 - cc @grpetersen1 - @HadidiSamer @RahulBanerjeeMD @szusmani et al.
18.11.2024 19:17 β π 10 π 3 π¬ 0 π 2
Thirsty boy!
15.11.2024 15:35 β π 5 π 0 π¬ 0 π 0
Myeloma & Amyloidosis Specialist
Karmanos Cancer Institute
Detroit, Michigan
Head of Campaigns at Myeloma UK. Mum, volunteer, new to running, always busy.
Kraft family chair and Myeloma doctor @danafarber, Professor @harvardmed, Immediate past President @Myeloma_Society
Washington U. School of Medicine.
Assoc Director Hem/Onc Fellowship.
Myeloma, Amyloidosis, Leukemia, Lymphoma & BMT physician and researcher.
As quoted in the Manchester Evening News. I hope the fame doesnβt destroy me.
haematology registrar PMCC & RMH | research affiliate, PORTAL, BWH/HMS | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer
Sharing, educating and inspiring for all things haematological.
#MedEd
Following every haematology type of person we can find.
Account currently managed by @christiplady.bsky.social
Cell biologist interested in chromosome instability | EMBO postdoc @ University of Oxford
Not a doctor or scientist;
Spouse dx'ed with MM in 2020;
Hope > hype.
Hematologist interested in plasma cell disorders and precursor conditions! π¨π¦π²π½ @Arthur Child Comprehensive Cancer Center, Calgary, AB, Canada
Myeloma clinician and researcher, health tech enthusiast
HΓ¦matolog pΓ₯ Rigshospitalet. // Myeloma doc
https://orcid.org/0000-0002-1754-5336
Molecular biologist. π§¬Principal investigator at University of Amsterdam π³π± Research interests: immune repertoire diversification mechanisms, oncogenic signaling, B-cells, multiple myeloma #medsky #scisky #academicsky #biosky
Post-doc in Myeloma research @AUMC. Interested in signal transduction, metabolomics, stromal interactions and other haematological malignancies.
MD PhD
NO Crypto NO MAGA NO MAHA NO TRUMP No DM
Malignant Hematology and Solid Tumor Genetics. Physician/Cytogeneticist. Opinions my own/ #MedSky #HemeSky
ARC is accelerating the development of and access to new and innovative treatments for systemic #amyloidosis
Views my own. VP Clinical Partnerships @TempusAI
#PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://coi.asco.org/share/RBB-TT6R/Michael
Epigenetic Inheritance, Neuroscience & anything biology-related
https://www.odedrechavilab.com/
TED: https://shorturl.at/myFTY
Huberman Lab Podcast: https://youtu.be/CDUetQMKM6g